Companies: 10,795·Total market cap: $144.5T
CSL Limited

CSL Limited

CSLLYOTCHealthcare● Active
$17.12
+$0.00(+0.00%)
Market Cap$66.3B
P/E Ratio
52W High$44.855
52W Low$16.29
Overview

CSL Limited(CSLLY)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CSLLY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$0.46cslly eps ttm · cslly earnings per shareEarnings history
PE Ratio (TTM)36.8×cslly pe ratio ttm · cslly price to earningsPE Ratio deep dive
Revenue (TTM)$30.5Bcslly revenue ttm · cslly annual revenueFull revenue history
Dividend Yield2.86%does cslly pay dividends · cslly dividend yieldDividend history
Shares Outstanding3.87Bcslly shares outstanding · cslly floatShares outstanding history
Next EarningsTBAcslly earnings date · cslly next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$15.43B▲ +4.26% YoY
202320242025
csl limited revenue · cslly revenue 2025
FY 2025Net Income$3.00B▲ +13.63% YoY
202320242025
csl limited net income · cslly profit 2025
FY 2025EPS$0.39▲ +14.71% YoY
202320242025
cslly eps · csl limited earnings per share 2025
TTM:Revenue: $30.52BNet Income: $4.18BEPS: $0.46View income statement →

股票表现

完整历史
1D+0.00%
1W+3.88%
1M-21.14%
3M-31.93%
YTD-40.56%
1Y-56.84%
5Y-70.05%

关于 CSL Limited

CEOGordon Naylor DipCompSc
IPO DateDec 29, 2009
Employees32,698
CountryAU
Websitecsl.com.au

CSL Limited is a global biopharmaceutical enterprise dedicated to the research, development, production, marketing, and distribution of a wide array of biopharmaceutical and related healthcare product…

what is csl limited · cslly stock overview · csl limited company profile · who is csl limited ceo · cslly OTC · csl limited headquarters · csl limited business segments

关于股票概览与关键数据

CSL Limited(CSLLY)是 Biotechnology 行业的 Healthcare 类公司,于 Dec 29, 2009 在 OTC 上市。截至最近交易日,CSLLY 股价为 $17.12,市值约为 $66.3B。过去12个月累计回报 -56.84%,年初至今回报 -40.56%。

2025 财年 CSL Limited 营收 $15.4B。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,CSL Limited(CSLLY)股价为 $17.12,在 OTC 上市,52周区间为 $16.29 – $44.85。

CSLLY 最新股价CSLLY quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议